rx 821002 has been researched along with Acute Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coventry, TL; Finn, DP; Harbuz, MS; Hudson, AL; Jessop, DS; Kinoshita, H; Nutt, DJ | 1 |
Houghton, AK; Westlund, KN | 1 |
2 other study(ies) available for rx 821002 and Acute Disease
Article | Year |
---|---|
Imidazoline2 (I2) receptor- and alpha2-adrenoceptor-mediated modulation of hypothalamic-pituitary-adrenal axis activity in control and acute restraint stressed rats.
Topics: Acute Disease; Adrenergic alpha-Antagonists; Animals; Corticosterone; Dose-Response Relationship, Drug; Hypothalamo-Hypophyseal System; Idazoxan; Imidazoles; Imidazoline Receptors; Injections, Intraperitoneal; Ligands; Male; Pituitary-Adrenal System; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Drug; Restraint, Physical; Stress, Psychological; Time Factors | 2004 |
An I2 imidazoline ligand, RS 45041, potentiates hyperalgesia in acute arthritis.
Topics: Acute Disease; Adrenergic alpha-Antagonists; Animals; Arthritis; Drug Evaluation, Preclinical; Drug Synergism; Hyperalgesia; Idazoxan; Imidazoles; Imidazoline Receptors; Indoles; Injections, Spinal; Isoindoles; Neural Inhibition; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Drug | 1996 |